Sort   by:  
 Page size 
UnknownAdvancing Equity in Rare Disease Research: Insights From the Undiagnosed Disease Network.
Not available
S-EPMC11698638 | biostudies-literature
UnknownGenome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.
Not available
S-EPMC3729927 | biostudies-literature
UnknownClonal haematopoiesis and risk of chronic liver disease.
Not available
S-EPMC10405350 | biostudies-literature
UnknownGenetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium.
Not available
S-EPMC8059115 | biostudies-literature
UnknownSequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.
Not available
S-EPMC7875770 | biostudies-literature
UnknownSARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Not available
S-EPMC9762734 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownHigher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
UnknownHigher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10156147 | biostudies-literature
Sort   by:  
 Page size